ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Hammersmith Medicines Research (Properties) Limited

Hammersmith Medicines Research (Properties) Limited is an active company incorporated on 20 November 2014 with the registered office located in Brighton, East Sussex. Hammersmith Medicines Research (Properties) Limited was registered 11 years ago.
Status
Active
Active since incorporation
Company No
09321577
Private limited company
Age
11 years
Incorporated 20 November 2014
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 20 November 2025 (1 month ago)
Next confirmation dated 20 November 2026
Due by 4 December 2026 (11 months remaining)
Last change occurred 1 month ago
Accounts
Due Soon
For period 1 Feb31 Jan 2024 (12 months)
Accounts type is Small
Next accounts for period 31 January 2025
Due by 31 January 2026 (26 days remaining)
Contact
Address
Pavilion View
19 New Road
Brighton
East Sussex
BN1 1EY
Same address since incorporation
Telephone
020 89614130
Email
Unreported
People
Officers
1
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Jul 1939
Dr Malcolm James Boyce
PSC • British • Lives in UK • Born in Jul 1939
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Human Medicines Research Limited
Dr Malcolm James Boyce is a mutual person.
Active
HMR Limited
Dr Malcolm James Boyce is a mutual person.
Active
Trio Medicines Limited
Dr Malcolm James Boyce is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Jan 2024
For period 31 Jan31 Jan 2024
Traded for 12 months
Cash in Bank
£100
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£1.02M
Increased by £7.13K (+1%)
Total Liabilities
-£1.06M
Increased by £7.7K (+1%)
Net Assets
-£42.86K
Decreased by £571 (+1%)
Debt Ratio (%)
104%
Increased by 0.03% (0%)
Latest Activity
Confirmation Submitted
1 Month Ago on 26 Nov 2025
Hammersmith Medicines Research Limited (PSC) Resigned
1 Month Ago on 12 Nov 2025
Malcolm James Boyce (PSC) Appointed
1 Month Ago on 12 Nov 2025
Small Accounts Submitted
7 Months Ago on 21 May 2025
Charles Kevin O'brien Resigned
11 Months Ago on 31 Jan 2025
Confirmation Submitted
1 Year 1 Month Ago on 2 Dec 2024
Small Accounts Submitted
1 Year 11 Months Ago on 30 Jan 2024
Confirmation Submitted
2 Years 1 Month Ago on 20 Nov 2023
Small Accounts Submitted
2 Years 8 Months Ago on 25 Apr 2023
Compulsory Strike-Off Discontinued
2 Years 8 Months Ago on 12 Apr 2023
Get Credit Report
Discover Hammersmith Medicines Research (Properties) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 20 November 2025 with updates
Submitted on 26 Nov 2025
Cessation of Hammersmith Medicines Research Limited as a person with significant control on 12 November 2025
Submitted on 17 Nov 2025
Notification of Malcolm James Boyce as a person with significant control on 12 November 2025
Submitted on 17 Nov 2025
Accounts for a small company made up to 31 January 2024
Submitted on 21 May 2025
Termination of appointment of Charles Kevin O'brien as a secretary on 31 January 2025
Submitted on 3 Feb 2025
Confirmation statement made on 20 November 2024 with no updates
Submitted on 2 Dec 2024
Accounts for a small company made up to 31 January 2023
Submitted on 30 Jan 2024
Confirmation statement made on 20 November 2023 with no updates
Submitted on 20 Nov 2023
Accounts for a small company made up to 31 January 2022
Submitted on 25 Apr 2023
Compulsory strike-off action has been discontinued
Submitted on 12 Apr 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year